Matches in Nanopublications for { ?s ?p "[KRAS (P=0.0075) or GNAS mutations (P=0.0256) were associated with poor overall survival in all patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[KRAS (P=0.0075) or GNAS mutations (P=0.0256) were associated with poor overall survival in all patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[KRAS (P=0.0075) or GNAS mutations (P=0.0256) were associated with poor overall survival in all patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1124609.RATvhsA3XVHmWEiGJf277XjCEsaVJmcjwQg6voy0N-6hc130_assertion description "[KRAS (P=0.0075) or GNAS mutations (P=0.0256) were associated with poor overall survival in all patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124609.RATvhsA3XVHmWEiGJf277XjCEsaVJmcjwQg6voy0N-6hc130_provenance.
- NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_assertion description "[KRAS (P=0.0075) or GNAS mutations (P=0.0256) were associated with poor overall survival in all patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124611.RAVYKCa1Ax5yHD59by6bK7UGsA7XsF4mr4vDTAe0FGMrw130_provenance.
- NP429843.RABWrd2N3FlLueDxJVINW4RIvyU8nVDTwEv-WFUUlMyrY130_assertion description "[KRAS (P=0.0075) or GNAS mutations (P=0.0256) were associated with poor overall survival in all patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429843.RABWrd2N3FlLueDxJVINW4RIvyU8nVDTwEv-WFUUlMyrY130_provenance.
- NP527764.RAxorkZlldqQWB8QEOUXLZagHcBCHpHNjMbQpTses9uEU130_assertion description "[KRAS (P=0.0075) or GNAS mutations (P=0.0256) were associated with poor overall survival in all patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527764.RAxorkZlldqQWB8QEOUXLZagHcBCHpHNjMbQpTses9uEU130_provenance.